Anika Therapeutics, Inc. Total Assets
Anika Therapeutics, Inc. (ANIK) had Total Assets of $183.47 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-07-29
- 2026-06-30: Assets $183.47M.
- 2026-03-31: Assets $179.39M.
- 2025-12-31: Assets $190.27M.
- 2025-09-30: Assets $189.44M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $183.47M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $179.39M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $190.27M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $189.44M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $187.68M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $190.60M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $202.74M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $231.41M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $262.65M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $263.74M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $270.63M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $328.16M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $328.88M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $339.07M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $349.13M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $347.75M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $354.12M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $342.24M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $347.54M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $352.93M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $363.13M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $362.25M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $365.61M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $416.34M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $440.52M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $398.91M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $330.71M 10-K/A · filed 2021-04-26 | |
| 2019-09-30 | $319.58M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $287.36M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $306.66M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $278.99M 10-K · filed 2020-03-06 | |
| 2018-09-30 | $269.26M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $265.41M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $284.34M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $282.62M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $273.13M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $265.00M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $247.37M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $240.25M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $231.06M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $222.74M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $214.46M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $235.75M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $222.85M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $208.01M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $197.68M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $192.81M 10-K · filed 2016-03-10 | $194.00M 10-K · filed 2015-03-13 |
| 2014-09-30 | $185.50M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $179.10M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $174.06M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $156.04M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $156.88M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $148.39M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $141.36M 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $142.07M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $134.87M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $136.38M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $133.23M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $132.84M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $129.78M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $131.39M 10-Q/A · filed 2011-08-10 | |
| 2010-12-31 | $128.94M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |